Date: August 17, 2020 Source 1: Ruhr-University Bochum Source 2: www.sciencedaily.com Summary: Even patients with suppressed immune systems can achieve a strong immune response to Sars-Cov-2. A test helps to adapt therapy following an infection. A research team from the University Hospital at Ruhr-Universität Bochum (RUB) has developed a test that provides information on the […]
Date: July 20, 2020 Source 1: University of Washington Health Sciences/UW Medicine Source 2: www.sciencedaily.com Summary: A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization. These antibodies potently neutralize the virus in young and old animals. The antibody levels induced
NIAID-sponsored Phase 1 trial tested mRNA vaccine Date: July 14, 2020 Source 1: NIH/National Institute of Allergy and Infectious Diseases Source 2: www.sciencedaily.com Summary: An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to
